WallStSmart
OM

Outset Medical Inc

NASDAQ: OM · HEALTHCARE · MEDICAL DEVICES

$4.36
+2.11% today

Updated 2026-05-01

Market cap
$81.71M
P/E ratio
P/S ratio
0.68x
EPS (TTM)
$-5.37
Dividend yield
52W range
$3 – $22
Volume
0.2M

Outset Medical Inc (OM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-98.0%
Last 4 quarters
Revenue YoY growth
-2.0%
Most recent quarter
EPS YoY growth
+84.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-13.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-19.1%
2026-02-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-11$-0.84-250.0%$4.70$3.80-19.1%
2025-11-05$-0.69-6.2%$12.77$11.81-7.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.24$-0.84-250.0%$28.87M-2.0%
2025-09-30$-0.65$-0.69-6.2%$29.43M+2.7%
2025-06-30$-0.98$-0.84+14.3%$31.42M+14.7%
2025-03-31$-0.94$-3.24-244.7%$29.75M+5.6%
2024-12-31$-6.19$-5.55+10.3%$29.47M-3.4%
2024-09-30$-6.32$-5.85+7.4%$28.67M-5.6%
2024-06-30$-0.45$-0.47-4.4%$27.39M-24.0%
2024-03-31$-0.55$-0.57-3.6%$28.17M-15.8%
2023-12-31$-0.61$-0.59+3.3%$30.51M
2023-09-30$-0.67$-0.71-6.0%$30.36M
2023-06-30$-0.78$-0.90-15.4%$36.04M
2023-03-31$-0.74$-0.90-21.6%$33.47M

Frequently asked questions

Has Outset Medical Inc beaten earnings estimates?
Outset Medical Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -98.0% over the last 4 quarters.
How does OM stock react to earnings?
OM stock has moved an average of -13.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Outset Medical Inc's revenue growth rate?
Outset Medical Inc reported year-over-year revenue growth of -2.0% in its most recent quarter, with EPS growing +84.9% year-over-year.